Unique PlaqueTec Liquid Biopsy System will be used to collect blood samples containing biomolecules localizing at or being released by coronary plaque.
Unique device operation offers faster procedure times, lower complications compared to current treatment options for stroke patients with underlying ICAD.
Collaboration with CardioNXT provides navigation and mapping system integration with Pulse Biosciences’ nsPFA circumferential catheter to support treatments.
Trial will examine the safety and performance of a bioelectric device in patients with mild to moderately severe Crohn’s disease and ulcerative colitis.